HPV vaccination trends from 2016 to 2025: Progress and missed opportunities
by: Alexandra Miller, MPH Human papillomavirus (HPV) is one of the most common sexually...
by: Alexandra Miller, MPH Human papillomavirus (HPV) is one of the most common sexually...
Closed claims no longer reflect real-world GLP-1 treatment patterns GLP-1 utilization continues to...
As the new year begins, many patients refocus on weight management and long-term health goals. At...
Artificial intelligence is no longer something healthcare and life sciences teams are testing on...
October is Breast Cancer Awareness Month. While pink ribbons and fundraising campaigns help bring...
Few areas of medicine have captured public interest over the past two years quite like...
AI-driven mortality models are supposed to provide accurate, data-backed insights into patient...
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1...
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly...
HealthVerity COO Andrew Goldberg recently sat down with Quest Diagnostics’ Director, Health...
A better way to measure healthcare costs in closed claims data This is the second post in our four-part taXonomy X blog series (part 1 here), and here we’ll discuss one of the most common pain points in closed claims analytics: costs. Specifically, w...